The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Pharma Mar’s lurbinectedin (Zepzelca) to treat ...

Closing the critical gap between HCPs’ need for information and the pharma industry’s ability to deliver relevant, tailored ...

Trixeo is the first and only triple-combination therapy approved in the EU for patients 12 years and older, independent of ...

Eli Lilly and InnoCare Pharma, a biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, have ...

If approved, this would be the first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica ...

Explore why long-term clinical trial engagement is a behavioural challenge, showing how proactive support from site teams can ...

As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate ...

CSL Seqirus has announced a strengthened partnership with the UK government that will see the UK become the first country in ...

Kondru joined the Emmes Group in 2024 and most recently served as CEO of Veridix, the company’s AI, technology, and data ...

The SAB brings together leading global experts with complementary expertise across Alzheimer’s disease biology, biomarkers, ...

Avalere Health was the night’s most awarded agency, with Novo Nordisk, Roche and The Urology Foundation topping the client leaderboard The Pharmaceutical Marketing Innovation and Impact Awards – PMis ...

Celebrating the Communiqué Awards 2026!; Forging a connection with patients through creativity; GLP-1s and the consumer lifestyle shift ...